The DOI matches its Crossref record.
Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease.
Open accessAbstract
BACKGROUND: Recurrent sustained ventricular tachycardia (VT) is not responsive to antiarrhythmic drugs in the majority of patients, who therefore need therapy with nonpharmacological methods. We evaluated prospectively the feasibility, safety, and efficacy of transcatheter radiofrequency (RF) ablation of VT in 21 selected patients with ischemic heart disease and VT. METHODS AND RESULTS: Twenty-one patients with ischemic heart disease and recurrent, drug-refractory VT documented by 12-lead ECG were selected who had sufficient hemodynamic tolerance of VT to undergo transcatheter mapping. Documented clinical VT was reproduced by programmed cardiac stimulation (PCS), and the site of origin was localized by a combination of techniques, including pace mapping, activation-sequence mapping, recordings of middiastolic potentials, and application of resetting and entrainment principles. RF current at 55 V was applied (3.8 +/- 3.1 applications per patient) for as long as 30 seconds at a time to target sites. Twenty-four distinct clinical VTs (mean cycle length, 445 +/- 52 milliseconds) were mapped and ablated in 21 patients. In 17 of 21 patients (81%), the procedure was acutely successful, and the target clinical VT could no longer be induced by PCS after the procedure, whereas in 4 patients, clinical VT remained inducible. By contrast, VTs with shorter cycle length and different QRS morphology than the ablated VT could still be induced by PCS in 12 of 21 patients. One patient died in intractable congestive heart failure 10 days after the procedure, and the remaining 20 are alive at the end of the follow-up period. The majority of the patients continued to be treated with at least one additional mode of antiarrhythmic therapy; 12 patients were still taking antiarrhythmic drugs, and 9 patients received an implantable cardioverter/defibrillator. During a mean follow-up period of 13.2 +/- 5.0 months, 9 of 20 patients (45%) had recurrent VT. In 4 patients, the recurrent VT was different than the previously ablated one. Clinical VT recurred in all 4 patients in whom RF ablation had been acutely unsuccessful. Four patients with recurrent VT underwent repeat RF ablation procedures that were acutely successful and had no further recurrence. CONCLUSION: Transcatheter RF ablation is feasible but has only moderately high efficacy in a small, selected group of patients with ischemic heart disease and drug-refractory, highly frequent, hemodynamically tolerated, sustained VT. In the majority of the patients, this treatment technique is palliative rather than definitive, and many of the patients continue to require other methods of antiarrhythmic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
Kuck, K.-H., Schaumann, A., Eckardt, L., Willems, S., Ventura, R., Delacrétaz, E., Pitschner, H.-F., Kautzner, J., Schumacher, B., & Hansen, P. S. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61755-4 · Cited by 799
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Della Bella, P., Hindricks, G., Jaïs, P., Josephson, M. E., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.030 · Cited by 770
Writing Committee Members, Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., et al. (2006) · Europace · doi:10.1093/europace/eul108 · Cited by 738
Nakagawa, H., Yamanashi, W. S., Pitha, J. V., Arruda, M., Wang, X., Ohtomo, K., Beckman, K. J., McClelland, J. H., Lazzara, R., & Jackman, W. M. (1995) · Circulation · doi:10.1161/01.cir.91.8.2264 · Cited by 625
Authors/Task Force Members (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl199 · Cited by 523
Calkins, H., Epstein, A., Packer, D., Arria, A. M., Hummel, J., Gilligan, D. M., Trusso, J., Carlson, M., Luceri, R., Kopelman, H., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00615-x · Cited by 417
Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Bella, P. D., Hindricks, G., Jais, P., Josephson, M. E., et al. (2009) · Europace · doi:10.1093/europace/eup098 · Cited by 416
The 1998 NASPE Prospective Catheter Ablation Registry
SCHEINMAN, M. M., & HUANG, S. (2000) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2000.tb00891.x · Cited by 374
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
SOSA, E., SCANAVACCA, M., D'AVILA, A., PICCIONI, J., SANCHEZ, O., VELARDE, J. L., SILVA, M., & REOLÃO, B. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00907.x · Cited by 330
Radio-Frequency Ablation as Treatment for Cardiac Arrhythmias
Morady, F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400707 · Cited by 281
TANNER, H., HINDRICKS, G., VOLKMER, M., FURNISS, S., KÜHLKAMP, V., LACROIX, D., DE CHILLOU, C., ALMENDRAL, J., CAPONI, D., KUCK, K., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01563.x · Cited by 265
Metadata
- Authors
- Kim, Y. H., Sosa-Suarez, G., Trouton, T. G., O'Nunain, S. S., Osswald, S., McGovern, B. A., Ruskin, J. N., & Garan, H.
- Venue
- Circulation
- Published
- 1994-03
- Volume
- 89
- Issue
- 3
- Pages
- 1094-1102
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1990944444
- Cited by
- 219
- References
- 0
- FWCI
- 13.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.